Christoph Kleinschnitz
Essen University Hospital
1 paper found
Refreshing results…
Ocrelizumab Extended Interval Dosing in Multiple Sclerosis in Times of COVID-19
Download from doi.orgMissing publications? Search for publications with a matching author name.